de-Freitas NR, Lima
LB, de-Moura MB, Veloso-Guedes CCF, Simamoto-Jnior PC, de-Magalhes D. Bisphosphonate treatment and dental implants: A
systematic review. Med Oral Patol Oral Cir Bucal. 2016 Sep 1;21
(5):e644-51.
doi:10.4317/medoral.20920
http://dx.doi.org/doi:10.4317/medoral.20920
1.
Drake MT, Clarke BL, Lewiecki EM. The Pathophisiology and Treatment of Osteoporosis. Clin
Ther. 2015;37:1837-50. |
|
|
|
2.
Madrid C, Sanz M. What impact
do systemically administrated
bisphosphonates have on oral implant therapy? A systematic review. Clin Oral Implants Res. 2009;20 Suppl
4:S87-95. |
|
|
|
3. Shabestari GO, Shayesteh YS, Khojasteh A, Alikhasi M, Moslemi N, Aminian A, et al. Implant Placement in Patients with Oral Bisphosphonate Therapy: A Case
Series. Clin Implant Dent Relat Res. 2010;12:175-80. |
|
|
|
4.
Montoya-Carralero JM, Parra-Mino P, Ramrez-Fernndez P, Morata-Murcia IM, Mompen-Gabn MC, Calvo-Guirado
JL. Dental implants in patients
treated with oral bisphosphonates: A bibliographic
review. Med Oral Patol
Oral Cir Bucal. 2010;15:e65-9. |
|
|
|
5. Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, et al.
American Association of Oral and Maxillofacial Surgeons position
paper on medication-related osteonecrosis
of the jaw-2014 update. J
Oral Maxillofac Surg.
2014;72:1938-56. |
|
|
|
6.
Marx RE. Pamidronate (Aredia)
and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing
epidemic. J Oral Maxillofac
Surg. 2003;61:1115-7. |
|
|
|
7. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151:264-9. |
|
|
|
8. Fugazzotto PA, Scott Lightfoot
W, Jaffin R, Kumar A. Implant Placement With or Without
Simultaneous Tooth Extraction in Patients Taking Oral Bisphosphonates: Postoperative Healing, Early Follow-Up, and the Incidence of Complications in Two Private Practices. J Periodontol. 2007;78:1664-9. |
|
|
|
9. Memon S, Weltman RL, Katancik JA. Oral Bisphosphonates:
Early Endosseous Dental Implant Success and Crestal Bone Changes. A Retrospective Study. Int J Oral Maxillofac Implants.
2012;27:1216-22. |
|
|
|
10. Koka S, Suresh Babu NM, Norell A. Survival of dental implants in
post-menopausal bisphosphonate
users. J Prosthodont Res.
2010;54:108-11. |
|
|
|
11.
Kwon TG, Lee CO, Park JW, Choi SY, Rijal G, Shin HI. Osteonecrosis associated with dental implants in patients undergoing bisphosphonate treatment. Clin. Oral Implants Res.
2014;25:632-40. |
|
|
|
12. Zahid TM, Wang BY, Cohen RE. Influence
of Bisphosphonates on
Alveolar Bone Loss Around Osseointegrated Implants. J Oral Implantol.
2011;37:335-46. |
|
|
|
13.
Bell BM, Bell RE. Oral Bisphosphonates and Dental Implants: A Retrospective Study. J Oral Maxillofac Surg. 2008;66:1022-4. |
|
|
|
14. Grant BT, Amenedo C, Freeman K, Kraut RA. Outcomes of Placing Dental Implants in Patients Taking Oral Bisphosphonates: A Review of 115 Cases. J Oral Maxillofac
Surg. 2008;66:223-30. |
|
|
|
15.
Jacobsen C, Metzler P, Rssle
M, Obwegeser J, Zemann W,
Grtz KW. Osteopathology induced by bisphosphonates
and dental implants: clinical
observations. Clin Oral Investig. 2013;17:167-75. |
|
|
|
16. Siebert T, Jurkovic R, Statelova D, Strecha J. Immediate implant placement in a patient with osteoporis undergoing bisphosphonate therapy: 1-year preliminary prospective study. J Oral Implantol. 2015;41:360-5. |
|
|
|
17.
Martin DC, O'Ryan FS, Indresano
AT, Bogdanos P, Wang B, Hui RL, et al. Characteristics of Implant Failures in Patients With a History of Oral Bisphosphonate Therapy. J Oral Maxillofac Surg.
2010;68:508-14. |
|
|
|
18.
Lpez-Cedrn JL , Sanromn JF , Garca A, Pe-arrocha M , Feijoo JF , Limeres
J, et al. Oral bisphosphonate-related osteonecrosis of the jaws in dental implant patients: a case series. Br J Oral Maxillofac
Surg. 2013;51:874-9. |
|
|
|
19. Lazarovici TS, Yahalom R, Taicher S, Schwartz-Arad D, Peleg
O, Yarom N. Bisphosphonate
Related Osteonecrosis of the Jaw Associated
With Dental Implants. J
Oral Maxillofac Surg.
2010;68:790-6. |
|
|
|
20. Goss A, Mark Bartold M, Sambrook P, Peter Hawker P. The Nature and Frequency of Bisphosphonate-Associated
Osteonecrosis of the Jaws in Dental Implant Patients: A South Australian
Case Series. J Oral Maxillofac Surg.
2010;68:337-43. |
|
|
|
21. Tam Y, Kar K, Nowzari H, Cha HS, Ahn KM. Osteonecrosis of the Jaw after
Implant Surgery in Patients Treated with Bisphosphonates - A Presentation of Six Consecutive Cases. Clin Implant Dent Relat Res. 2014;16:751-61. |
|
|
|
22. Durieux N, Vandenput S, Pasleau F. [OCEBM levels of evidence system]. Rev Med Liege.
2013;68:644-9. |
|
|
|
23. Holzinger D, Seemann R, Matoni N, Ewers R, Millesi W, Wutzl A. Effect of Dental Implants on Bisphosphonate-Related Osteonecrosis of the Jaws. J Oral Maxillofac Surg. 2014;72:e1.1937-8. |
|
|
|
24. Javed F, Almas K. Osseointegration
of Dental Implants in Patients
Undergoing Bisphosphonate
Treatment: A Literature Review. J Periodontol.
2010;81:479-84. |
|
|
|
25.
Serra MP, Llorca CS, Donat
FJ. Oral implants in patients
receiving bisphosphonates:
a review and update. Med Oral Patol Oral Cir Bucal.
2008;13:E755-60. |
|
|
|
26.
Ata-Ali J, Ata-Ali F, Pe-arrocha-Oltra D, Galindo-Moreno
P. What is the impact of bisphosphonate therapy upon dental implant survival?. A systematic review and meta-analysis. Clin Oral Implants Res.
2016;27:e38-46. |
|
|
|
27.
Yip JK, Borrell LN, Cho SC, Francisco H, Tarnow DP. Association between oral bisphosphonate use
and dental implant failure
among middle-aged women. J Clin Periodontol. 2012;39:408-14. |
|
|
|
28.
Marx RE, Cillo JE Jr,
Ulloa JJ. Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum
CTX testing, prevention,
and treatment. J Oral Maxillofac
Surg. 2007;65:2397-410. |
|
|
|
29. Ruhin B. Implants and biphosphonates: 2012 guidelines
for practitioners. Rev Stomatol Chir Maxillofac Chir Orale. 2013;114:1-3. |
|
|
|
30. Otomo-Corgel J. Osteoporosis and Osteopenia: Implications for periodontal
and implant therapy. Periodontology 2000. 2012;59:111-39. |